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Abstract
Iron is essential for all known life due to its redox properties, however these same properties can also lead
to its toxicity in overload through the production of reactive oxygen species. Robust systemic and cellular
control are required to maintain safe levels of iron and the liver seems to be where this regulation is mainly
located. Iron misregulation is implicated in many diseases and as our understanding of iron metabolism
improves the list of iron-related disorders grows. Recent developments have resulted in greater knowledge
of the fate of iron in the body and have led to a detailed map of its metabolism, however a quantitative
understanding at the systems level of how its components interact to produce tight regulation remains
elusive.
A mechanistic computational model of human liver iron metabolism, which includes the core regula-
tory components, is presented here. It was constructed based on known mechanisms of regulation and on
their kinetic properties, obtained from several publications. The model was then quantitatively validated
by comparing its results with previously published physiological data, and it is able to reproduce multiple
experimental findings. A time course simulation following an oral dose of iron was compared to a clinical
time course study and the simulation was found to recreate the dynamics and time scale of the systems
response to iron challenge. A disease state simulation of haemochromatosis was created by altering a
single reaction parameter that mimics a human haemochromatosis gene (HFE) mutation. The simulation
provides a quantitative understanding of the liver iron overload that arises in this disease.
This model supports and supplements understanding of the role of the liver as an iron sensor and
provides a framework for further modelling, including simulations to identify valuable drug targets and
design of experiments to improve further our knowledge of this system.
Author Summary
Iron is an essential nutrient required for healthy life but, in excess, is the cause of debilitating and even
fatal conditions. The most common genetic disorder in humans caused by a mutation, haemochromatosis,
results in an iron overload in the liver. Indeed the liver plays a central role in the regulation of iron.
Recently, an increasing amount of detail has been discovered about molecules related to iron metabolism,
but an understanding of how they work together and regulate iron levels (in healthy people) or fail to do
it (in disease) is still missing. We present a mathematical model of the regulation of liver iron metabolism
that provides explanations of its dynamics and allows further hypotheses to be formulated and later tested
in experiments. Importantly, the model reproduces accurately the healthy liver iron homeostasis and
simulates haemochromatosis showing how the causative mutation leads to iron overload. We investigate
how best to control iron regulation and identified reactions that can be targets of new medicines to treat
iron overload. The model provides a virtual laboratory for investigating iron metabolism and improves
understanding of the method by which the liver senses and controls iron levels.
2Introduction
Iron is an essential element from archaea to complex eukaryotes and man [1], and is required for many
processes including oxygen transport, DNA synthesis and respiration. Iron deficiency is the most common
nutritional deficiency affecting a large proportion of all humans [2]. The redox activity which provides
iron’s utility also means poorly regulated iron metabolism can lead to highly toxic free radicals [3].
Maintaining the delicate balance of iron requires robust cellular and systemic regulation since both iron
deficiency and overload can cause cell death [4]. Recent research has lead to a much greater understanding
of the mechanisms controlling iron metabolism and a global view of the interactions between iron-related
components is beginning to emerge [5, 6].
The liver has been proposed to play a central role in the regulation of iron homeostasis [7] through
the action of the recently discovered hormone hepcidin [8]. Hepcidin is expressed predominantly in the
liver [9] and distributed in the serum to control systemic iron metabolism. Hepcidin acts on ferroportin
to induce its degradation. Ferroportin is the sole iron exporting protein in mammalian cells [10], therefore
hepcidin expression reduces iron export into the serum from enterocytes, and reduces iron export from the
liver. Intracellular iron metabolism is controlled by the action of iron response proteins (IRPs) [11]. IRPs
post-transcriptionally regulate mRNAs encoding proteins involved in iron metabolism. IRPs combined
with ferritin and the transferrin receptors (TfR) make up the center of cellular iron regulation. Ferritin is
the iron-storage protein forming a hollow shell which counters the toxic effects of free iron by storing iron
atoms in a chemically less reactive ferrihydrite [12]. Extracellular iron circulates bound to transferrin
(Tf), and is imported into the cell through the action of membrane bound proteins transferrin receptors
1 and 2 (TfR1 and TfR2). Human haemochromatosis protein (HFE) competes with transferrin bound
iron for binding to TfR1 and TfR2 [13].
Systems Biology provides an excellent methodology for elucidating understanding, through compu-
tational modelling, of the complex iron metabolic network. A quantitative model of iron metabolism
allows for a careful and principled examination of the effect of the various components of the network.
Modelling allows one to do “what-if” experiments leading to new hypotheses that can later be put to
test experimentally. However, no comprehensive model of liver iron metabolism exists to date. Models
have been published that cover specific molecular events only, such as the loading of iron in ferritin [14].
A qualitative map of mammalian iron metabolism provides a detailed overview of the molecular interac-
tions involved in iron metabolism, including in specific cell types [6]. Similarly, a detailed model of iron
metabolism and oxidative stress was described but uses a Boolean approach and is specific for yeast [15].
Quantitative models of the iron network have been recently described [16, 17], yet these include only a
few components of the iron network. The model from Chifman et al. suggests that the dynamics of this
iron network is stable [16]. Large-scale models of the metabolism of the hepatocyte [18,19] and a generic
human metabolism stoichiometric model [20] have also been published, but these contain only four reac-
tions relating to iron metabolism. While they include iron transport, the receptors are not considered,
and regulatory details are absent altogether.
Existing models are therefore at two extremes of detail: very specific and very generic — but to address
questions about hepatic iron regulation, what is desirable is a model that balances coverage and detail.
This is the aim of the present work. One of the problems of modelling iron metabolism quantitatively
and in detail arises from the lack of parameter values for many interactions. Recently, several of those
parameters have been described in the literature (Table 2), particularly using technologies like surface
plasmon resonance. This has enabled us to construct a detailed mechanistic kinetic model of human
hepatocyte iron metabolism. The model has been validated by being able to reproduce data from several
disease conditions — importantly, these physiological data were not used in constructing the model. This
validation provides a sense of confidence that the model is indeed appropriate for understanding liver
iron regulation and for predicting the response to various environmental perturbations.
3Results
Our model was constructed based on many published data on individual molecular interactions (see Meth-
ods section), and is available in Systems Biology Markup Language (SBML) and COPASI formats in sup-
plementary data, as well as from BioModels (http://identifiers.org/biomodels.db/MODEL1302260000)
[21]. Figure 1 depicts a process diagram of the model, using the Systems Biology Graphical Notation
(SBGN) standard [22], where all the considered interactions are shown. It is important to highlight that
while results described below are largely in agreement with observations, the model was not forced to
replicate them. The extent of agreement between model and physiological data provides confidence that
the model is accurate enough to carry out “what-if” type of experiments that can provide quantitative
explanation of iron regulation in the liver.
Steady State
Initial validation of the model was performed by assessing the ability to recreate experimentally-observed
steady-state concentrations of metabolites and rates of reactions. Simulations were run to steady state
using the parameters and initial conditions from Tables 1 and 2. Table 3 compares steady-state concen-
trations of metabolites and reaction rates with experimental observations.
Chua et al. [23] injected radio-labeled transferrin bound iron into the serum of mice and measured
the total uptake of the liver after 120 minutes. The uptake rate, when expressed as mol/s, was close to
that found at steady state by the computational model (Table 3).
A technical aspect of note in this steady state solution, is that it is very stiff. This originates because
one section of the model is orders or magnitude faster than the rest: the cycle composed of iron binding
to ferritin, internalization and release. Arguably this could be resolved by simplifying the model, but
the model was left intact because this cycling is an important aspect of iron metabolism and allows the
representation of ferritin saturation. Even though the stiffness is high, our software is able to cope by
using an appropriate numerical method.
Response to Iron Challenge
An oral dose of iron creates a fluctuation in serum transferrin saturation of approximately 10% [24]. The
fixed serum iron concentration in the simulation was replaced by a transient increase in concentration
equivalent to a 10% increase in transferrin saturation as a simulation of oral iron dosage on hepatocytes.
The simulated hepcidin response (Figure 2A) is consistent with the hepcidin response measured by Girelli
et al. [24] (Figure 2B & C). The time scale and dynamics of the hepcidin response to iron challenge has
been accurately replicated in the simulation presented here. Although the exact dynamics of the simulated
response is not validated by either experimental technique (mass spectrometry or ELISA) the simulation
appears to present an approximation of the two experimental techniques reaching a peak between 4 and
8 hours and returning to around basal levels within 24 hours.
Cellular Iron Regulation
The computational model supports the proposed role of HFE and TFR2 as sensors of systemic iron.
Figure 3B shows that as the concentration of HFE bound to TfR2 (HFE-TfR2) increases with serum
transferrin-bound iron (Tf-Fe intercell), at the same time the abundance of HFE bound to TfR1 (HFE-
TfR1) decreases. The increase in HFE-TfR2 complex, even though of small magnitude, promotes in-
creased expression of hepcidin (Figure 3A). It is through this mechanism that liver cells sense serum
iron levels and control whole body iron metabolism through the action of hepcidin. Although the labile
iron pool increases with serum transferrin-bound iron in this simulation, this is only because the model
4does not include the action of hepcidin in reducing duodenal export of iron. Expression and secretion of
hepcidin will have a global effect of reducing the labile iron pool.
Hereditary Haemochromatosis Simulation
Hereditary haemochromatosis is the most common hereditary disorder with a prevalence higher than 1
in 500 [25]. Type 1 haemochromatosis is the most common and is caused by a mutation in the HFE gene
leading to a misregulation of hepcidin and consequent systemic iron overload.
A virtual HFE knockdown was performed by reducing 100-fold the rate constant for HFE synthesis
in the model, to create a simulation of type 1 hereditary haemochromatosis. The simulation was run to
steady state and results were compared with experimental findings.
Qualitative validation showed the in silico HFE knockdown could reproduce multiple experimental
findings as shown in Table 4. Quantitatively the model was unable to reproduce accurately the finding that
Hfe -/- mice have 3 times higher hepatic iron levels [26]. This was due to the fixed intercellular transferrin
bound iron concentration in the model, unlike in Hfe -/- mice where there is an increase in transferrin
saturation as a result of increased intestinal iron absorption [26]. Despite fixed extracellular conditions
the model predicted an intracellular hepatocyte iron overload which would be further compounded by the
systemic effects of the misregulation of hepcidin. The simulation recreated increased ferroportin levels
despite the expression of ferroportin remaining the same as wild type which was consistent with mRNA
measurements from Ludwiczek et al. [27]. mRNA based experiments can be used to validate expression
rates and protein assays are able to validate steady state protein concentrations as both expression rates
and steady state protein concentrations are available as results from the computational model. The model
of haemochromatosis was also able to replicate the dynamics of experimental responses to changing dietary
iron conditions. An approximate 2-fold increase in hepatic ferroportin expression is caused by increased
dietary iron in both haemochromatosis and healthy mice [27]. The model presented here recreated this
increase with increasing intercellular iron as can be seen in Figure 4.
HFE knockout has been shown to impair the induction of hepcidin by iron in mouse [27], and human
[28] hepatocytes and this was seen in the computational model as increasing transferrin bound iron did
not induce hepcidin as strongly in HFE knockdown.
Although an increase in transferrin receptor 2 was observed in the model (1.77µM healthy; 2.80µM
type 1 haemochromatosis), the up-regulation was slightly smaller than the change observed in vivo [29].
This is due to the model having fixed extracellular transferrin bound iron concentration, in contrast to
haemochromatosis where this concentration increases due to higher absorption in the intestine.
Type 3 haemochromatosis results in similar phenotype as type 1 haemochromatosis, however the
mutation is found in the TfR2 gene as opposed to HFE. A virtual TfR2 knockdown mutation was
performed by decreasing 100-fold the rate constant of synthesis of TfR2 from the model. Model results
were then compared with the findings of Chua et al. [23]. The simulation showed a steady state decrease
of liver TfR1 from 0.29µM to 0.19µM with TfR2 knockdown. This is supported by an approximate
halving of TfR1 levels in TfR2 mutant mice [23]. An increase in hepcidin and consequent decrease in
ferroportin as seen in mice was matched by the simulation.
An iron overload phenotype with increased intracellular iron is not recreated by the model of the
TfR2 mutant. This is, again, due to the fixed serum transferrin-bound iron concentration, while in the
whole body there would be increased iron absorption from the diet through the effect of hepcidin.
Metabolic Control Analysis
Metabolic control analysis (MCA) is a standard technique to identify the reactions that have the largest
influence on metabolite concentrations or reaction fluxes in a steady state [30,31]. MCA is a special type
of sensitivity analysis and thus is used to quantify the distributed control of the biochemical network. A
control coefficient measures the relative change of the variable of interest caused by a small change in the
5reaction rate (e.g. a control coefficient can be interpreted as the percentage change of the variable given
a 1% change in the reaction rate).
The control over the concentration of the labile iron pool by each of the model reactions can be seen
in Table 5. The synthesis and degradation of TfR2, TfR1, HFE and the formation of their complexes
were found to have the highest control over the labile iron pool. Synthesis and degradation of IRP was
also found to have some degree of control, but synthesis and degradation of hepcidin have surprisingly a
very small effect on the labile iron pool.
The control over the hepcidin concentration was also measured (Table 6), as the ability to control
hepatic hepcidin levels could provide therapeutic opportunities to control whole system iron metabolism,
due to its action on other tissues. Interestingly, in addition to the expression and degradation of hepcidin
itself, the expression of HFE and degradation of HFETfR2 complex have almost as much control over
hepcidin. The expression of TfR2 has a considerably lower effect, though still significant.
Flux control coefficients were also determined which indicate the control that reactions have on a
chosen reaction flux. The flux control coefficients for the ferroportin mediated iron export reaction
are given in Table 7. This reaction is of particular interest as it is the only method of iron export,
therefore controlling this reaction rate could be important in treating various iron disorders including
haemochromatosis and anemia. The reactions of synthesis and degradation of TfR1, TfR2 and HFE were
found to have high control, despite not having direct interactions with ferroportin. TfR1 and TfR2 may
show consistently high control due to having dual roles as iron importers and iron sensors which control
hepcidin expression.
A drawback of MCA, and any other local sensitivity analysis, is that it is only predictive for small
changes of reaction rates. However, the changes that result in disease states are usually large, and
experimental parameter estimation can result in large uncertainty. Thus a global sensitivity analysis was
also performed following the method described in [32]. This calculates the maximal and minimal values of
the sensitivity coefficients within a large space of parameter values. This technique is useful, for example,
if there is uncertainty about the values of the model parameters as it reveals the possible range of control
of each one given the uncertainty. All parameters were allowed to vary within ± 10% and the maximal
and minimal control coefficients were measured (Tables 5, 6 and 7).
In terms of the control of the labile iron pool (Table 5), the reactions with highest control in the refer-
ence steady state are still the ones with highest control in the global case (i.e. when all parameters have
an uncertainty of ±10%). However TfR1 expression, TfR1 binding, TfR1 degradation, IRP expression
and IRP degradation, which all have significant (but not the highest) control in the reference state, could
have very low control in the global sense. On the other hand HFETfR2 degradation, hepcidin expression,
hepcidin degradation and TfR2 binding 2, have low control in the reference steady state, but could have
significant control in the global sense. All other reactions have low control in any situation.
In the case of the control of hepcidin concentration (Table 6) the differences between the reference
state and the global are much smaller overall, and one could only identify a few reactions that have
moderate control in the reference, but could have a bit less in the global sense (TfR2 expression, TfR2
binding, and TfR2 iron internalisation).
In the case of the control of the flux of iron export (Table 7), we find some reactions with high
control in the reference that could have low control in the global sense: TfR1 expression, TfR1 biding,
TfR1 degradation, IRP expression and IRP degradation. Hepcidin expression, hepcidin degradation, and
HFETfR2 degradation have almost no control in the reference, but in the global sense they could exert
considerable control. This is very similar to the situation of the control of the labile iron pool.
Chifman et al. [16] analysed the parameter space of their core model of iron metabolism in breast
epithelial cells and concluded the system behavior is far more dependent on the network structure than
the exact parameters used. The analysis presented here lends some support to that finding, since only
a few reactions could have different effect on the system if the parameters are wrong. A further scan
of initial conditions for metabolites found that varying initial concentrations over 2 orders of magnitude
6had no affect on the steady state achieved (Table 3), indicating that the steady state found in these
simulations is unique.
Receptor Properties
It is known that the iron sensing by the transferrin receptors is responsive over a wide range of intercellular
iron concentrations [33]. The present model reproduces this well (Figure 6A, 1× turnover line). Becker et
al. argued that a linear response of a receptor to its signal over a wide range could be achieved through
a combination of: high receptor abundance, increased expression when required, recycling to the surface
of internalised receptors and high receptor turnover [34]. This was illustrated with the behaviour of
the erythropoietin (EPO) receptor [34]. Since the present model contains essentially the same type of
reactions that can lead to such a behaviour, simulations were carried out to investigate to what extent
this linearity of response is present here. In this case it is the response of the total amount of all forms of
TfR1 and TfR2 bound to Tf-Fe against the amount of Tf-Fe intercell that is important. A variable was
created in the model to reflect the total receptor response (see Material and Methods), and this variable
was followed in a time course response to an iron pulse (Figure 5A). The response to the iron pulse is
remarkably similar to the response of the EPO receptor to EPO [34].
Becker et al. [34] reported that the linearity of EPO-R response, i.e. the integral of the response
curve, is increased by increasing turnover rate of the receptor and this property was also observed in
the simulation of TfR1 response (Figure 6). The range in which the iron response is linear is smaller
than that found for EPO (Figure 6). As TfR1’s half life in the model matches the experimentally
determined value [35] the non-linear receptor response seen in the simulation is expected to be accurate.
This suggests that TfR1 is a poor sensor for high levels of intercellular iron. On the other hand TfR2
is more abundant than TfR1 [35] and accordingly shows an increased linearity for a greater range of
intercellular iron concentrations (Figure 7). This suggests the two transferrin receptors play different
roles in sensing intercellular iron levels with TfR2 providing a wide range of sensing and TfR1 sensing
smaller perturbations. The activation of TfR2 directly influences the expression of hepcidin and therefore
it is desirable for it to sense large systemic imbalances. TfR1 does not modulate hepcidin expression itself
instead it plays a primary role as an iron transporter .
Discussion
Iron is an essential element of life, in humans it is involved in oxygen transport, respiration, biosynthesis,
detoxification, and other processes. Iron regulation is essential because iron deficiency results in debili-
tating anemia, while iron excess leads to free radical generation and is involved in many diseases [3]. It
is clear that healthy life depends on tight regulation of iron in the body. The mechanisms involved in
iron absortion, transport, storage and regulation form a complex biochemical network [6]. The liver has
a central role in the regulation of systemic iron metabolism through secretion of the peptide hormone
hepcidin.
Here we analysed the hepatic biochemical network involved in iron sensing and regulation through
a mathematical model and computer simulation. The model was constructed mostly based on in vitro
biochemical data, such as protein complex dissociation constants. The model was then validated by
comparison with experimental data from multiple physiological studies at both steady state and during
dynamic responses. Where quantitative data were available the model matched these well and also quali-
tatively recreated many findings from clinical and experimental investigations. The simulation accurately
modelled the highly prevalent iron disorder haemochromatosis. The disease state was simulated through
altering a single parameter of the model and showed quantitatively how an iron overload phenotype
occurs in patients with a HFE mutation.
7Due to the limited availability of quantitative clinical data on human iron metabolism, various other
data sources, particularly from in vitro experiments and animal models, were integrated for the parame-
terisation of this model. This computational modelling effort constitutes a clinical translational approach,
enabling data from multiple sources to improve our understanding of human iron metabolism. Several
arguments could be raised to cast doubt on this approach, such as the the failure of in vitro conditions
to mimic those in vivo or the difference between animal models and humans. This means that this type
of data integration must be carefully monitored in terms of establishing the validity of the resulting
model. Examining the behaviour of the model by simulating it at different values of initial conditions or
other parameters (parameter scans) is important to establish the limits of utility of the model. Global
sensitivity analysis is another approach that determines the boundaries of parameter variation that the
model tolerates before it becomes too distant from the actual system behaviour. Model validation is
an essential step in modelling. Validation should be carried out by enquiring if the model is able to
match experimental observations that were not used to calibrate it. Here the model was validated by the
simulation of haemochromatosis disease, where the model behaviour matched the clinical data (Table 4).
The precise regulatory mechanism behind transferrin receptors and HFE controlling hepcidin ex-
pression remains to be validated experimentally, however the model presented here supports current
understanding that the interaction of TfR2 and HFE form the signal transduction pathway that leads to
the induction of hepcidin expression [36].
The global metabolic control analysis results support the identification of the transferrin receptors,
particularly TfR2, and HFE as potential therapeutic targets; a result that is robust even to inaccuracies
in parameter values. Although hepcidin would be an intuitive point of high control of this system
(and therefore a good therapeutic target), in the present model this is not the case. It seems that
targeting the promoters of hepcidin expression may be more desirable. However this conclusion has to
be expressed with some reservation that stems from the fact that the global sensitivity analysis identified
the hepcidin synthesis and degradation reactions in the group of those with the largest uncertainty. By
changing parameter values by no more than 10% it would be possible to have the hepcidin expression
and degradation show higher control. So it seems important that the expression of hepcidin be studied
in more detail. We also predict that the control of hepcidin over the system would be higher if the model
had included the regulation of intestinal ferroportin by hepatic ferroportin.
The global sensitivity analysis, however, allows taking strong conclusions about the reactions for
which the reference steady state is not much different from the maximal and minimal values. It turns
out that these are the reactions that have the largest and the smallest control over the system variables.
For example, the reactions with greatest control on the labile iron pool and iron export are those of
the HFE-TfR2 system. But the reactions of the HFE-TfR1 system have always low control. These two
conclusions are valid under a wide range of parameter values.
Construction of this model required several assumptions to be made due to lack of measured param-
eter values, as described in Material and Methods. These assumptions may or may not have a large
impact on the model behaviour, and it is important to identify those that have a large impact, as their
measurement will improve our knowledge the most. Of all the assumptions made, the rates of expression
and degradation of ferroportin are those that have a significant impact on the labile iron pool in the
model (see Table 5). This means that if the values assumed for these rate parameters were to be signif-
icantly different the model prediction for labile iron pool behaviour would also be different. The model
is therefore also useful by suggesting experiments that will optimally improve our knowledge about this
system.
Limitations on the predictive power of the model occur due to the scope of the system chosen. Fixed
serum iron conditions, which were used as boundary conditions in the model, do not successfully recreate
the amplifying feedbacks that occur as a result of hepcidin expression controlling enterocyte iron export.
To relieve this limitation, a more advanced model should include dietary iron uptake and the action of
hepcidin on that process.
8The model predicts a quasi-linear response to increasing pulses of serum iron, similar to what has
been predicted for the erythropoietin system [34]. Our simulations display response of the transferrin
receptors to pulses of extracellular transferrin-bound iron that is similar to the EPO-R response to EPO
(Figure 6). The integral of this response versus the iron sensed deviates very little from linearity in the
range of physiological iron (Figure 5).
Computational models are research tools whose function is to allow for reasoning in a complex non-
linear system. The present model can be useful in terms of predicting properties of the liver iron system.
These predictions form hypotheses that lead to new experiments. Their outcome will undoubtedly im-
prove our knowledge and will also either confirm the accuracy of the model or refute it (in which case it
then needs to be corrected). The present model and its results identified a number of predictions about
liver iron regulation that should be investigated further:
• changes in activity of the hepcidin gene in the liver have little effect on the size of the labile iron
pool,
• the rate of expression of HFE has a high control over the steady state level of hepcidin,
• the strong effect of HFE is due to its interaction with TfR2 rather than TfR1,
• the rate of liver iron export by ferroportin has a strong dependence on the expression of TfR1, TfR2
and HFE,
• the rate of expression of hepcidin is approximately linear with the concentration of plasma iron
within the physiological range.
The present model is the most detailed quantitative mechanistic model of cellular iron metabolism to
date, allowing for a comprehensive description of its regulation. It can be used to elucidate the link from
genotype to phenotype, as demonstrated here with hereditary haemochromatosis. The model provides
the ability to investigate scenarios for which there are currently no experimental data available — thus
making predictions about the system and aiding in experimental design.
Materials and Methods
The model is constructed using ordinary differential equations (ODEs) to represent the rate of change
of each chemical species. COPASI [37] was used as the software framework for model construction,
simulation and analysis. Cell Designer [38] was used for construction of a SBGN process diagram (Figure
1).
The model consists of 2 compartments representing the serum and the liver. Concentrations of haeme
and transferrin bound iron in the serum were fixed to represent constant extracellular conditions. Fixed
metabolites simulate a constant influx of iron through the diet as any iron absorbed by the liver is
effectively replenished. A labile iron pool (LIP) consumption reaction is added to represent various uses
of iron and create a flow through the system. Some of the LIP consumption reaction would be attributed
to heme biosynthesis however this process was not considered explicitly in this study to avoid unnecessary
complexity and because the bone marrow is the major site of heme biosynthesis [39].
Initial concentrations for metabolites were set to appropriate concentrations based on a literature
survey (Table 1). All metabolites formed through complex binding were set to zero initial concentrations
(Table 1). The concentration of a chemical species at a time point in the simulation is determined by
integrating the system of ODEs. For some proteins a half-life was available in the literature, but sources
could not be found for their synthesis rates (translation). In this occurrence, estimated steady-state
concentrations were used from the literature and a synthesis rate was chosen such that at steady state
the concentration of the protein would be approximately accurate, following Equation 1:
9d[P]
dt
= +k − d[P] = 0. (1)
This is solved for k where [P] is the steady-state concentration of the protein and d is the degradation
rate obtained from the half-life (λ) using:
d =
ln 2
λ
. (2)
Complex formation reactions, such as binding of TfR1 to Tf-Fe for iron uptake, are modelled using
the on and off binding constants as a forward and reverse mass action reaction. For example:
TfR1 + Tf-Fe⇋ Tf-Fe-TfR1 (3)
is modelled using two reactions:
TfR1 + Tf-Fe
ka
→ Tf-Fe-TfR1 (4)
Tf-Fe-TfR1
kd
→ TfR1 + Tf-Fe (5)
There is one ODE per each chemical species. The two reactions 4 and 5 add the following terms to
the set of ODEs:
d[TfR1]
dt
=− ka[TfR1][TF-Fe] + kd[Tf-Fe-TfR1] . . .
d[Tf-Fe]
dt
=− ka[TfR1][TF-Fe] + kd[Tf-Fe-TfR1] . . .
d[Tf-Fe-TfR1]
dt
=+ ka[TfR1][TF-Fe]− kd[Tf-Fe-TfR1] . . .
(6)
Intracellular haeme levels are controlled by a balance between uptake, export and oxygenation. haeme
import through the action of haeme carrier protein 1 (HCP1), export by ATP-binding cassette sub-family
G member 2 (ABCG2) and oxygenation by haeme oxygenase-1 (HO-1) follow Michaelis-Menten kinetics.
HO-1 expression is promoted by haeme through by a Hill function (Equation (7)).
v = [S] · a·
(
[M]nH
KnH + [M]nH
)
, (7)
v = [S] · a·
(
1−
[M]nH
KnH + [M]nH
)
. (8)
Where S is the substrate, M is the modifier, a is the turnover number, K is the ligand concentration
which produces half occupancy of the binding sites of the enzyme, and nH is the Hill coefficient. Values
of nH larger than 1 produce positive cooperativity (i.e. a sigmoidal response); when nH = 1 the response
is the same as Michaelis-Menten kinetics. A Hill coefficient of nH = 1 was assumed unless there is
literature evidence for a different value. Where K is not known it has been estimated to be of the order
of magnitude of experimentally observed concentrations for the ligand.
IRP/Iron-responsive elements (IRE) regulation is represented by Hill kinetics using Equation (7) to
simulate the 3’ binding of IRP promoting the translation rate, and Equation (8) to represent the 5’
binding of IRP reducing the translation rate. Ferroportin degradation is modelled using 2 reactions: one
representing the standard half-life and the other representing the hepcidin-induced degradation. A Hill
equation (Equation 7) is used to simulate the hepcidin-induced degradation of ferroportin.
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Hepcidin expression is the only reaction modelled using a Hill coefficient greater than 1. Due to
the small dynamic range of HFE-TfR2 concentrations a Hill coefficient of 5 was chosen to provide the
sensitivity required to produce the expected range of hepcidin concentrations. The mechanism by which
HFE-TfR2 interactions induce hepcidin expression is not well understood, but is thought to involve the
mitogen-activated protein kinase (MAPK) signalling pathway [40]. The stimulus/response curve of the
MAPK cascade has been found to be equivalent to a cooperative enzyme with a Hill coefficient of 4-5 [41],
making the steep Hill function appropriate to model hepcidin expression.
Ferritin modelling follows the work of Salgado et al. [14]. Iron from the LIP binds to, and is internalised
in, ferritin with mass action kinetics. Internalised iron release from ferritin occurs through 2 reactions
(intact ferritin release and release due to ferritin degradation). The average amount of iron internalised
per ferritin affects the iron release rate and this is modelled using Equation 9 (adapted from [14]):
v = [S] · kloss ·

1 + 0.048 ·
[FT1]
[FT]
1 + [FT1][FT]

 . (9)
Where S is internalised iron, kloss is the rate constant and [FT1]/[FT] is the ratio of iron internalised
in ferritin to total ferritin available. The value 0.0048 was obtained by dividing the value given in Salgado
et al. [14] by 50 as that simulation was scaled for 50 iron atom packages.
Iron is also released from ferritin when the entire ferritin cage is degraded. The kinetics of ferritin
degradation are mass action, however the amount of iron released when a ferritin cage is degraded is
an average based on ferritin levels and total iron internalised in ferritin. Incorporating mass action and
ferritin saturation ratio gives the following rate law for FT1 → LIP:
v = [S] · k ·
[FT1]
[FT]
. (10)
Iron export rate was modelled using Equation 7 with ferroportin as the modifier and a Hill coefficient
of 1. K was assumed to be around the steady state concentration of IRP (1µM). A rate (V) of 40pm ·
(106cells · 5min)−1 was used from Sarkar et al. [42] and these values were substituted into the equation
and solved for a.
Ferroportin expression rates and degradation rates are poorly understood. Ferroportin abundance
data [43] lead to an estimate of ferroportin concentration around 0.16µM . The hepcidin induced degra-
dation of ferroportin is represented in the model by a rate law in the form of Equation 7 with a Hill
coefficient nH = 5 (see above) and a K
nH equal to the measured concentration of hepcidin [44] (see Table
1). We then assume a maximal rate of degradation to be 1 nMs−1, and using the steady state concen-
tration of ferroportin, the rate constant can be estimated as 0.0002315 s−1. The ferroportin synthesis
rate was then calculated to produce the required steady-state concentration of ferroportin at the nominal
hepcidin concentration.
The HFE-TfR2 binding and dissociation constants were also not available and so it was assumed that
they were the same as those of TfR1-HFE. Finally, the HFE-TfR and HFE-TfR2 degradation rates are
also not known; we used a value that is an order of magnitude lower than the half life for unbound TfR
(i.e. we assume the complex to be more stable than the free form of TfR).
Although DMT1 may contribute towards transferrin bound iron uptake in hepatocytes this contribu-
tion has been found to be minor and DMT1 knockout has little affect on iron metabolism [45], therefore
DMT1 was not included in the model.
The two iron response proteins (IRP1 and IRP2) which are responsible for cellular iron regulation
were modelled as a single metabolite in this study as the mechanistic differences in their regulatory roles
is poorly understood. Equivalent regulation by both IRPs has been found in multiple studies [46–48].
Global sensitivity analysis was performed using the method proposed by Sahle et al. [32], where all
parameter values were allowed to vary within ±10% of their nominal value in the model and we search for
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the maximum and minimum value that concentration- or flux-control coefficients of interest are able to
reach within that parameter space. The searches were carried out with the particle swarm optimisation
algorithm [49]. In order to process these optimisations in a reasonable time a HTCondor [50] distributed
computing system was used, managed through the Condor-COPASI package [51].
To perform analysis of receptor response in a similar manner to the EPO system studied by Becker et
al. [34] initial conditions were adjusted to recreate a similar virtual experiment. Haeme concentration was
fixed at zero to isolate transferrin bound iron uptake. The rate constant of the labile iron pool depletion
reaction was reduced to balance the reduced iron uptake (which results in iron having a similar half-life
to EPO in [34]). Initial concentrations for all metabolites were set to steady-state concentrations with
the exception of the labile iron pool and iron bound to all receptors which were set to zero. Extracellular
transferrin bound iron was allowed to vary and set at increasing concentrations to determine receptor
response. Time courses were calculated for Tf-Fe-TfR1, 2(Tf-Fe)-TfR1, Tf-Fe-TfR2 and 2(Tf-Fe)-TfR2
as iron binds its two receptors in a two-staged process. Two new variables were defined in COPASI which
integrated the results of the time courses corresponding to the two receptors (in their different ligand
states):
Int TfR1 binding =
∫
[TfFeTfR1] · dt+
∫
[2(TfFe)TfR1] · dt, (11)
Int TfR2 binding =
∫
[TfFeTfR2] · dt+
∫
[2(TfFe)TfR2] · dt. (12)
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Figure Legends
Figure 1. SBGN process diagram of human liver iron metabolism model. The compartment
with yellow boundary represents the hepatocyte, while the compartment with pink boundary represents
plasma. Species overlayed on the compartment boundaries represent membrane-associated species.
Abbreviations: Fe: iron, FPN1: ferroportin, FT: ferritin, HAMP: hepcidin, haeme: intracellular haeme,
haeme intercell: plasma haeme, HFE: human haemochromatosis protein, HO-1: haeme oxygenase 1,
IRP: iron response protein, LIP: labile iron pool, Tf-Fe intercell: plasma transferrin-bound iron, TfR1:
transferrin receptor 1, TfR2: transferrin receptor 2. Complexes are represented in boxes with the
component species. In the special case of the ferritin-iron complex symbol, the amounts of each species
are not in stoichiometric amounts (since there are thousands of iron ions per ferritin).
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Figure 2. Simulated time course concentrations of hepcidin in response to changing serum
transferrin-bound iron levels. The model shows similar dynamics to time course samples from
patients measured by mass spectrometry and ELISA by Girelli et al., 2011 [24]. Hereditary
haemochromatosis simulations show reduced hepcidin levels and peak response compared to WT (Wild
Type).
Figure 3. Simulated steady state concentrations of metabolites in response to increasing
serum Tf-Fe. Increasing HFE-TfR2 complex as a result of HFE-TfR1 reduction induces increased
hepcidin.
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Figure 4. Ferroportin expression rate in the model doubles in response to changing serum
iron concentrations as verified experimentally. HFE knock-down (HH) simulations and WT
simulation of Fe-Tf against ferroportin (Fpn) expression.
Figure 5. Iron and Epo receptors show a similar response following an impulse of ligand.
Ligand receptor binding for iron shows a distinctive curve which closely resembles EPO receptor
binding studied by Becker et al. 2010 [34] (their Fig. 2B).
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Figure 6. Increasing receptor turnover increases the linearity of the response for
transferrin receptor 1. The range of linear response for the transferrin receptor depends on its
half-life. This effect was first demonstrated in the EPO receptor by Becker et al. 2010 [34] who found
similar behavior (their Fig. 4D).
Figure 7. TfR2 response versus intercellular transferrin-bound iron. The response is
approximately linear over a wide range of intercellular iron concentrations.
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Tables
Table 1. Initial Conditions. Initial concentrations of all metabolites and the source for their value.
Parameter Initial Concentration (mol/l) Source
LIP 1.3E-6 [52]
FPN1 1E-9
IRP 1.16E-06 [53]
HAMP 5E-9 [44]
haeme 1E-9
2(Tf-Fe)-TfR1 Internal 0
2(Tf-Fe)-TfR2 Internal 0
Tf-Fe-TfR2 Internal 0
Tf-Fe-TfR1 Internal 0
Tf-TfR1 Internal 0
Tf-TfR2 Internal 0
Fe-FT 0
FT 1.66E-10 [54]
HO-1 3.56E-11 [55]
FT1 0
Tf-Fe intercell 5E-6 fixed, [56]
TfR 4E-7 [35]
Tf-Fe-TfR1 0
HFE 2e-07 [35]
HFE-TfR 0
HFE-TfR2 0
Tf-Fe-TfR2 0
2(Tf-Fe)-TfR1 0
2HFE-TfR 0
2HFE-TfR2 0
2(Tf-Fe)-TfR2 0
TfR2 3E-6 [35]
haeme intercell 1e-07 [57]
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Table 2. Reactions, rate laws and kinetic constant values.
Name Reaction Rate law Parameters Source
Fpn Export LIP → Tf-Fe intercell; FPN1 Hill Function → a=15 mol s−1, nH = 1,
k=1E-6 mol
[42]
TfR1 expression → TfR; IRP Hill Function → a=6e-12 s−1, nH = 1, k=1e-
6 mol
[35]
TfR1 degradation TfR → Mass action k=8.37e-06 s−1 [56]
Ferroportin Expres-
sion
→ FPN1; IRP Hill Function -| a=4e-9 s−1, nH = 1, K =1e-
6 mol
IRP expression → IRP; LIP Hill Function -| a=4e-11 s−1, nH = 1,
K=1e-6 mol
[58]
IRP degradation IRP → Mass action k = 1.59e-5 s−1 [58]
Fpn degradation
Hepc
FPN1 → ; HAMP Hill Function → a=2.315E-5 s−1, nH = 1,
K=1e-9 mol
HFE degradation HFE → Mass action k = 6.418e-5 s−2 [59]
HFE expression → HFE Constant flux v = 2.3469e-11 mol (l · s)−1 [59]
TfR2 expression → TfR2 Constant flux v = 2e-11 mol (l · s)−1 [35]
TfR2 degradation TfR2 → ; Tf-Fe intercell Hill Function -| a=3.2e-05 s−1, nH = 1,
K=2.5e9 mol
[35]
Hepcidin expression → HAMP; 2HFE-TfR2 2(Tf-Fe)-
TfR2
Hill Function → a=5e-12 s−1, nH = 5,
K=1.35e-07 mol, a=5e-12
mol s−1, K=6e-7 mol
[44]
Hepcidin degrada-
tion
HAMP → Mass action k = 9.63e-05 s−1 [60]
Heme oxygenation Heme → LIP; HO-1 Henri-Michaelis-
Menten
kcat=17777.7 s−1, Km=2e-6
mol l−1
[61]
HFE TfR1 binding HFE + TfR → HFE-TfR Mass action k = 1.102e+06 l (mol · s)−1 [62]
HFE TfR1 release HFE-TfR → HFE + TfR Mass action k = 0.08 s−1 [62]
TfR1 binding Tf-Fe intercell + TfR → Tf-Fe-
TfR1
Mass action k = 837400 l (mol · s)−1 [62]
TfR1 release Tf-Fe-TfR1 → Tf-Fe intercell +
TfR
Mass action k = 9.142e-4 s−1 [62]
HFE TfR2 binding 2∗HFE + TfR2 → 2HFE-TfR2 Mass action k = 3.9438e+11 l2 (mol2 ·
s)−1
HFE TfR2 release 2HFE-TfR2 → 2 * HFE + TfR2 Mass action k = 0.0018 s−1
TfR2 binding Tf-Fe intercell + TfR2 → Tf-Fe-
TfR2
Mass action k = 222390 l (mol · s)−1 [62]
TfR2 release Tf-Fe-TfR2 → Tf-Fe intercell +
TfR2
Mass action k = 0.0061 s−1 [62]
TfR1 binding 2 Tf-Fe-TfR1 + Tf-Fe intercell →
2(Tf-Fe)-TfR1
Mass action k = 121400 l (mol · s)−1 [62]
TfR1 release 2 2(Tf-Fe)-TfR1 → Tf-Fe-TfR1 + Tf-
Fe intercell
Mass action k = 0.003535 s−1 [62]
HFE TfR1 binding 2 HFE-TfR + HFE → 2HFE-TfR Mass action k = 1.102e+06 l (mol · s)−1 [62]
HFE TfR1 release 2 2HFE-TfR → HFE-TfR + HFE Mass action k = 0.08 s−1 [62]
TfR2 binding 2 Tf-Fe-TfR2 + Tf-Fe intercell →
2(Tf-Fe)-TfR2
Mass action k= 69600 l (mol · s)−1 [62]
TfR2 release 2 2(Tf-Fe)-TfR2 → Tf-Fe-TfR2 + Tf-
Fe intercell
Mass action k = 0.024 s−1 [62]
TfR1 iron internali-
sation
2(Tf-Fe)-TfR1 → 4(LIP) + TfR Mass action k = 0.8333 l·s−1 [63]
Continued on next page
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Table 2 – Continued from previous page
Name Reaction Rate Law Parameters Source
TfR2 iron internali-
sation
2(Tf-Fe)-TfR2 → 4(LIP)-TfR2 Mass action k = 0.8333 l·s−1 [63]
outFlow LIP → Mass action (irre-
versible)
k = 4e-04 s−1
Ferritin Iron binding LIP + FT → Fe-FT Mass action k = 4.71e+10 l (mol · s)−1 [14]
Ferritin Iron release Fe-FT → LIP + FT Mass action k = 22922 s−1 [14]
Ferritin Iron inter-
nalisation
Fe-FT → FT1 + FT Mass action k = 108000 s−1 [14]
Ferritin internalised
iron release
FT1 → LIP; FT1 FT Kloss Hill kloss = 13.112 s−1 [14]
ferritin expression → FT; IRP Hill Function -| a=2.312e-13 s−1, nH = 1,
K=1e-06 mol
[54]
HO1 Degradation HO-1 → Mass action k= 3.209e-05 s−1 [64]
HO1 Expression → HO-1; Heme Hill Function → a=2.1432e-15 s−1, K=1e-9
mol
[65]
Ferritin Degradation
Full
FT → Mass action k = 1.203e-05 s−1 [14]
Heme uptake Heme intercell → Heme Henri-Michaelis-
Menten
Km=1.25e-4 mol, v=1.034e-
5 mol s−1
[66]
Heme export Heme → Heme intercell Henri-Michaelis-
Menten
Km=1.78e-05 mol, v=2.18e-
5 mol s−1
[67]
Ferritin Degradation
Full Iron Release
FT1 → LIP; FT1 FT Mass Action Ferritin k=1.203e-05 s−1 [14]
HFE-TfR degrada-
tion
2HFE-TfR → Mass action k=8.37e-07 s−1
HFE-TfR2 degrada-
tion
2HFE-TfR2 → Mass action k=8.37e-07 s−1
Continued on next page
Table 3. Steady State Validation — Comparison between model and experimental observations.
IRP, Ferritin and TfR are expressed in particles per cell assuming a cellular volume of 10−12 l. Iron per
Ferritin is a ratio.
Metabolite Model Experimental Reference
Labile Iron Pool 0.804µM 0.2− 1.5µM [52]
Iron Response Protein 836000 cell−1 ∼ 700000 cell−1 [68]
Ferritin 4845 cell−1 3000− 6000 cell−1 (mRNA), 2.5− 54600 cell−1(protein) [68], [69]
TfR 1.74× 105 cell−1 1.6− 2× 105 cell−1 [70]
TfR2 4.63× [TfR1] 4.5− 6.1× [TfR1] [35]
Iron per Ferritin 2272 average 2400 [71]
Hepcidin 5.32nM 3.5− 8.3nM [72]
Reaction Model Experimental Reference
TBI import rate 2.67µM s−1 2.08µM s−1 [23]
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Table 4. HFE Knockout Validation — The simulation of type-1 hereditary haemochromatosis
closely matches experimental findings at steady state.
Metabolite Model Experiment Reference
IRP - - [73]
LIP + + [73]
HAMP - - [74]
TfR2 + + [29]
Reaction Model Experimental Reference
TfR1/2 iron import + + [73]
FT expression + + [73]
TfR expression - - [73]
FPN expression ≈ = [27]
Table 5. Metabolic Control Analysis — Concentration control coefficients for the labile iron pool.
Reaction Local
Global
Minimum Maximum
TfR2 expression 0.894573 0.515971 1.41255
Fpn Export -0.825483 -0.924 -0.698754
TfR2 binding 0.569815 0.298433 0.901285
TfR2 degradation -0.563132 -0.898362 -0.293111
Fpn degradation 0.351397 0.186176 0.50289
Ferroportin Expression -0.351397 -0.502317 -0.176245
HFE expression -0.313525 -0.623067 0.346532
TfR1 expression 0.259758 0.0652 0.496352
TfR1 binding 0.259436 0.06577 0.497636
TfR1 degradation -0.258004 -0.503067 -0.0657364
IRP expresion 0.209893 0.0748546 0.300039
IRP degradation -0.209893 -0.347477 -0.0753367
HFE-TfR2 degradation -0.0341692 -0.684936 0.000229851
Hepcidin expression 0.0283652 0.0004375 0.6553120
Hepcidin degradation -0.0283652 -0.791216 -0.000576136
HFE degradation 0.0162284 -0.0259426 0.0386967
TfR2 binding 2 0.0100938 0.298433 0.901285
TfR2 release -0.0100938 -0.0194113 -0.00434313
HFE TfR2 binding -0.00668253 -0.0187053 0.0218869
HFE TfR2 release 0.0063856 -0.0205303 0.018034
TfR2 iron internalisation -0.00335169 -0.156882 0.000557494
HFE TfR1 binding -0.00143167 -0.0120993 0.0000742
HFE TfR1 release 0.00143166 0.0000760 0.0121124
HFE TfR1 binding 2 -0.00143166 -0.0121238 -0.0000739
HFE TfR1 release 2 0.00143165 0.0000738 0.0121135
HFE-TfR degradation -0.00143165 -0.0121249 -0.0000737
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Table 6. Metabolic Control Analysis — Concentration control coefficients for hepcidin.
Reaction Local
Global
Minimum Maximum
Hepcidin expression 1.00002 0.512257 1.487664
Hepcidin degradation -1.00002 -1.00027 -0.999001
HFE-TfR2 degradation -0.956041 -1.3943 -0.380497
HFE expression 0.9131 0.274035 1.30051
TfR2 expression 0.243052 0.0984356 0.486305
TfR2 degradation -0.153001 -0.293528 -0.0638787
TfR2 binding 0.128436 0.0558287 0.273304
TfR2 iron internalisation -0.128062 -0.272967 -0.0557919
HFE degradation -0.047263 -0.102578 -0.0122656
HFE TfR2 binding 0.0245645 0.00630724 0.0573883
HFE TfR2 release -0.023473 -0.0557905 -0.00602681
TfR2 binding 2 0.00227514 0.000811688 0.00589495
TfR2 release -0.00227514 -0.00589437 -0.000812498
HFE TfR1 binding -0.00093303 -0.00728765 -5.22895e-05
HFE TfR1 release 0.000933028 4.84169e-05 0.00697082
HFE TfR1 binding 2 -0.000933028 -0.0073373 -5.31758e-05
HFE TfR1 release 2 0.000933018 5.3417e-05 0.00731269
HFE-TfR degradation -0.000933018 -0.00733725 -5.69006e-05
TfR1 expression -0.000796332 -0.00607511 -4.36181e-05
TfR1 degradation 0.000790955 4.53395e-05 0.00623214
IRP expresion -0.000544238 -0.00281211 -4.71681e-05
IRP degradation 0.000544238 4.16666e-05 0.00351147
Fpn export -0.00045206 -0.00277642 -4.33404e-05
Fpn degradation 0.000192436 1.47897e-05 0.00153538
Ferroportin expression -0.000192436 -0.00153463 -1.41905e-05
TfR1 binding 0.000142075 3.78713e-06 0.00137383
TfR2 release 2 -6.36921e-05 -0.000176906 -2.18216e-05
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Table 7. Metabolic Control Analysis — Flux-control coefficients for the iron export out of the
liver compartment.
Reaction Local
Global
Minimum Maximum
TfR2 expression 0.910944 0.449405 1.38521
TfR2 binding 0.581149 0.285737 0.867434
TfR2 degradation -0.573438 -0.858215 -0.278218
HFE expression -0.353566 -0.669513 -0.187987
TfR1 expression 0.266964 0.0676606 0.510467
TfR1 binding 0.266601 0.0675083 0.51963
TfR1 degradation -0.265162 -0.51689 -0.0669265
IRP expresion 0.182446 0.063823 0.310888
IRP degradation -0.182446 -0.313848 -0.0656558
Fpn Export 0.151719 0.0626056 0.271594
Ferroportin Expression 0.0645849 0.0189112 0.149717
Fpn degradation -0.0645849 -0.149993 -0.0189094
HFE degradation 0.0183009 0.00812358 0.0401559
TfR2 release -0.0102946 -0.018781 -0.00414945
TfR2 binding 2 0.0102946 0.00414543 0.0187846
HFE TfR2 binding -0.0077113 -0.0191638 0.00292511
HFE TfR2 release 0.00736866 -0.00282598 0.0186586
Hepcidin expression -0.00521336 -0.1785377 -0.0000387334
Hepcidin degradation 0.00521336 5.77312e-05 0.224586
HFE-TfR2 degradation -0.00226218 -0.0183295 0.19571
HFE TfR1 binding -0.00143917 -0.0119501 -7.50839e-05
HFE TfR1 release 0.00143917 7.49065e-05 0.0119095
HFE TfR1 binding 2 -0.00143917 -0.0114124 -7.49686e-05
HFE TfR1 release 2 0.00143915 7.49046e-05 0.0116242
